Transmission of SARS-CoV-2 from mother to fetus or neonate: What to know and what to do?

被引:12
|
作者
De Luca, Daniele [1 ,4 ]
Vauloup-Fellous, Christelle [2 ]
Benachi, Alexandra [3 ]
Vivanti, Alexandre [3 ]
机构
[1] Paris Saclay Univ Hosp, APHP, Antoine Beclere Hosp, Div Pediat & Neonatal Crit Care, Clamart, France
[2] Paris Saclay Univ Hosp, APHP, Paul Brousse Hosp, Div Virol, Villejuif, France
[3] Paris Saclay Univ Hosp, APHP, Antoine Beclere Hosp, Div Obstet & Gynecol, Clamart, France
[4] Hop Antoine Beclere, Div Pediat & Neonatal Crit Care, 157 rue porte Trivaux, F-92140 Clamart, France
关键词
COVID-19; Pregnancy; Infant; Vertical; Infection; Stillbirth; NICU; SYNDROME CORONAVIRUS 2; SEPTIC SHOCK; INFECTION; COVID-19; PREGNANCY; PLACENTA; OUTCOMES; TMPRSS2; ACE2; BARRIER;
D O I
10.1016/j.siny.2023.101429
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
SARS-CoV-2 can be vertically transmitted from the mother to the fetus and the neonate. This transmission route is rare compared to the environmental or horizontal spread and therefore, the risk can be deemed inconse-quential by some medical providers. However, severe, although just as rare, feto-neonatal consequences are possible: fetal demise, severe/critical neonatal COVID-19 and multi-inflammatory syndrome (MIS-N) have been described. Therefore, it is important for the clinicians to know the mechanism of vertical transmission, how to recognize this, and how to deal with neonatal COVID-19 and MIS-N. Our knowledge about this field has significantly increased in the last three years. This is a summary of the pathophysiology, diagnostics, and therapeutics of vertical SARS-CoV-2 transmission that clinicians apply in their clinical practice.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Fetoplacental transmission and placental response to SARS-CoV-2: Evidence from the literature
    Ezechukwu, Henry C.
    Shi, Jiahua
    Fowora, Muinah A.
    Diya, Cornelius A.
    Elfaki, Faiz
    Adegboye, Oyelola A.
    FRONTIERS IN MEDICINE, 2022, 9
  • [42] Features of HLA class I expression and its clinical relevance in SARS-CoV-2: What do we know so far?
    Bouayad, Abdellatif
    REVIEWS IN MEDICAL VIROLOGY, 2021, 31 (06)
  • [43] SARS-CoV-2 genetic and immunology insights: what does the scientific community know so far?
    Cabrera, M.
    Salazar-Viedma, M.
    D'Afonseca, V
    GENETICS AND MOLECULAR RESEARCH, 2022, 21 (04):
  • [44] What is the significance of the conjunctiva as a potential transmission route for SARS-CoV-2 infections?
    Lange, Clemens
    Wolf, Julian
    Auw-Haedrich, Claudia
    Schlecht, Anja
    Boneva, Stefaniya
    Lapp, Thabo
    Agostini, Hansjuergen
    Martin, Gottfried
    Reinhard, Thomas
    Schlunck, Guenther
    OPHTHALMOLOGE, 2021, 118 (SUPPL 1): : 85 - 88
  • [45] SARS-CoV-2 Immunity in Hematopoietic Stem Cell Transplant and Cell Therapy Recipients: What Do We Know, and What Remains to Be Determined?
    Pinana, Jose Luis
    Guerreiro, Manuel
    Solano, Carlos
    HEMATO, 2023, 4 (02): : 170 - 183
  • [46] What is the importance of the conjunctiva as a potential transmission pathway for SARS-CoV-2 infections?
    Lange, Clemens
    Wolf, Julian
    Auw-Haedrich, Claudia
    Schlecht, Anja
    Boneva, Stefaniya
    Lapp, Thabo
    Agostini, Hansjuergen
    Martin, Gottfried
    Reinhard, Thomas
    Schlunck, Guenther
    OPHTHALMOLOGE, 2020, 117 (07): : 626 - 630
  • [47] The legacy of maternal SARS-CoV-2 infection on the immunology of the neonate
    Gee, Sarah
    Chandiramani, Manju
    Seow, Jeffrey
    Modestini, Carlotta
    Das, Abhishek
    Doores, Katie J.
    Tribe, Rachel M.
    Pollock, Emily
    Tree, Timothy
    Gibbons, Deena L.
    NATURE IMMUNOLOGY, 2021, 22 (12) : 1490 - +
  • [48] Colchicine Against SARS-CoV-2 Infection: What is the Evidence?
    Drosos, Alexandros A.
    Pelechas, Eleftherios
    Drossou, Vassiliki
    Voulgari, Paraskevi V.
    RHEUMATOLOGY AND THERAPY, 2022, 9 (02) : 379 - 389
  • [49] BCG and SARS-CoV-2 What Have We Learned?
    Kulesza, Jakub
    Kulesza, Ewelina
    Kozinski, Piotr
    Karpik, Wojciech
    Broncel, Marlena
    Fol, Marek
    VACCINES, 2022, 10 (10)
  • [50] SARS-CoV-2 infection in microglia and its sequelae: What do we know so far?
    Luo, Echo Yongqi
    Chang, Raymond Chuen-Chung
    Gilbert-Jaramillo, Javier
    BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2024, 42